Posters
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Sullivan et al., 2023
Related Articles
Profiling the tumor- immune landscape with a same-section multiomics assay
Posted on 01 Apr 2024
Read Post